Published on ASSET (http://www.asset-scienceinsociety.eu)

Home > Taxonomy term

influenza virus vaccine

Safety and immunogenicity of a live attenuated influenza H5 candidate vaccine strain A/17/turkey/Turkey/05/133 H5N2 and its priming effects for potential pre-pandemic use: a randomised, double-blind, placebo-controlled trial.

Pitisuttithum P, Boonnak K, Chamnanchanunt S, Puthavathana P, Luvira V, Lerdsamran H, et al. Lancet Infect Dis. 2017 Aug;17(8):833-842. 

Background: The emergence of highly pathogenic avian influenza H5N1 viruses has raised concerns about their pandemic potential. Vaccination is the most effective way of preventing influenza. In this study, we investigated the safety and immunogenicity of an avian H5N2 live attenuated influenza vaccine (LAIV H5N2) in healthy Thai adults and its priming immune responses with an H5N1 inactivated vaccine boost.

Target: 
Decision Makers, Government and Public Health, Healthcare Professionals
Topic: 
Epidemiology, Vaccination
Tags: 
influenza, pandemic, influenza virus vaccine

Stopping emerging influenza viruses at their origin

Krammer F. Lancet Infect Dis. 2017 Aug;17(8):784-786.

Target: 
Decision Makers, Government and Public Health, Healthcare Professionals
Topic: 
Epidemiology, Prevention, Vaccination
Tags: 
influenza, pandemic, influenza virus vaccine

Newsletters

Select the newsletter(s) to which you want to subscribe or unsubscribe.

News from Asset project
Responsible Research and Innovation Newsletter
Asset PPRB
E-mail *

Contacts

Contacts

General inquiries: info@asset-scienceinsociety.eu

ASSET

Action plan on Science in Society related issues in Epidemics and Total pandemics
European Commission
This project has received funding from the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement no 612236.
Source URL: http://www.asset-scienceinsociety.eu/tags/influenza-virus-vaccine